Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3.23M
-
Shares change
-
-350K
-
Total reported value, excl. options
-
$15.2M
-
Value change
-
-$2.04M
-
Number of buys
-
16
-
Number of sells
-
-14
-
Price
-
$4.70
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2018
37 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2018.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.23M shares
of 43.4M outstanding shares and own 7.44% of the company stock.
Largest 10 shareholders include BlackRock Inc. (903K shares), Nantahala Capital Management, LLC (878K shares), Vanguard Group Inc (294K shares), STATE STREET CORP (274K shares), NORTHERN TRUST CORP (190K shares), GEODE CAPITAL MANAGEMENT, LLC (131K shares), Bank of New York Mellon Corp (51.8K shares), SPHERA FUNDS MANAGEMENT LTD. (50K shares), MORGAN STANLEY (48.5K shares), and TIAA CREF INVESTMENT MANAGEMENT LLC (40.6K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.